InvestSMART

MedAdvisor Limited (ASX: MDR) - Announcements

Current share price for MDR : $0.022 0.002 (10%)+

ASX company news and announcements for MedAdvisor Limited (MDR) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All MedAdvisor Limited (MDR) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than MedAdvisor Limited (MDR), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for MedAdvisor Limited (MDR)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
- Co-Marketing & Licence Agreement with US Dispense Vendor PDX 20 Jun 2018 8:46AM $0.040 $0.022 fallen by 45%
- MDR Signs Agreement with EBOS Subsidiary ZEST 15 Jun 2018 9:57AM $0.042 $0.022 fallen by 47.62%
- MDR Release from Escrow and Appendix 3B 31 May 2018 9:21AM $0.043 $0.022 fallen by 48.84%
- Release of securities from voluntary escrow 17 May 2018 10:27AM $0.042 $0.022 fallen by 47.62%
- MedAdvisor to Launch Customised TerryWhite Chemmart App 3 May 2018 1:53PM $0.048 $0.022 fallen by 54.17%
- MDR March 2018 Quarterly Report & Appendix 4C 30 Apr 2018 9:44AM $0.045 $0.022 fallen by 51.11%
- Appendix 3B - Issue and Exercise of Options 16 Apr 2018 2:48PM $0.045 $0.022 fallen by 51.11%
- Corporate Governance Statement - 2017 13 Apr 2018 11:51AM $0.046 $0.022 fallen by 52.17%
- MedAdvisor Reaches 1 Million Connected Patients 6 Apr 2018 12:17PM $0.049 $0.022 fallen by 55.10%
- MDR H1 FY2018 Financial Report & Appendix 4D 26 Feb 2018 11:12AM $0.053 $0.022 fallen by 58.49%
- MDR December 2017 Quarterly Report & Appendix 4C 25 Jan 2018 11:32AM $0.049 $0.022 fallen by 55.10%
- Appendix 3B - Issue of Employee Options 2 Jan 2018 8:28AM $0.048 $0.022 fallen by 54.17%
- MDR - Release of Securities from Escrow 16 Nov 2017 8:37AM $0.051 $0.022 fallen by 56.86%
- Appendix 3B - Issue of Employee Incentive Options 14 Nov 2017 9:19AM $0.051 $0.022 fallen by 56.86%
- MDR Cleansing Notice - EBOS Placement 30 Oct 2017 12:38PM $0.051 $0.022 fallen by 56.86%
- Becoming a substantial holder 25 Oct 2017 3:33PM $0.047 $0.022 fallen by 53.19%
- EBO: EBOS investment in MedAdvisor 24 Oct 2017 10:29AM $0.046 $0.022 fallen by 52.17%
- 2017 AGM Results & Chairman's Address 24 Oct 2017 10:21AM $0.046 $0.022 fallen by 52.17%
- MDR AGM Investor Presentation 24 Oct 2017 10:01AM $0.047 $0.022 fallen by 53.19%
- Appendix 3B - EBOS Placement 24 Oct 2017 9:49AM $0.036 $0.022 fallen by 38.89%
- MedAdvisor $9.5m Investment from EBOS 24 Oct 2017 9:48AM $0.036 $0.022 fallen by 38.89%
- Trading Halt 20 Oct 2017 9:09AM $0.036 $0.022 fallen by 38.89%
- Appendix 3Y Change in Directors Interest - Xenos 19 Oct 2017 3:09PM $0.036 $0.022 fallen by 38.89%
- Appendix 3Y Change in Directors Interest - Swinnerton 19 Oct 2017 3:08PM $0.036 $0.022 fallen by 38.89%
- Appendix 3Y Change in Directors Interest - Read 19 Oct 2017 3:06PM $0.036 $0.022 fallen by 38.89%

626 - 650 of 761 results

Page 26 of 31

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.